Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Ambrisentan |
Description | Ambrisentan |
Keywords | Ambrisentan, Letairis, Ambrisentan REMS, Letairis REMS,LetairisREMS.com,Mylan,Gilead,Teva,Par,SigmaPharm,Apotex,SunPharma |
WebSite | ambrisentanrems.us.com |
Host IP | 40.142.87.232 |
Location | United States |
Site | Rank |
US$7,459,908
Last updated: 2023-05-18 01:26:45
ambrisentanrems.us.com has Semrush global rank of 1,418,825. ambrisentanrems.us.com has an estimated worth of US$ 7,459,908, based on its estimated Ads revenue. ambrisentanrems.us.com receives approximately 860,759 unique visitors each day. Its web server is located in United States, with IP address 40.142.87.232. According to SiteAdvisor, ambrisentanrems.us.com is safe to visit. |
Purchase/Sale Value | US$7,459,908 |
Daily Ads Revenue | US$6,887 |
Monthly Ads Revenue | US$206,583 |
Yearly Ads Revenue | US$2,478,985 |
Daily Unique Visitors | 57,384 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
ambrisentanrems.us.com. | A | 3599 | IP: 40.142.87.232 |
ambrisentanrems.us.com. | NS | 28800 | NS Record: ns1.ubc.com. |
ambrisentanrems.us.com. | NS | 28800 | NS Record: ns2.ubc.com. |
ambrisentanrems.us.com. | TXT | 3600 | TXT Record: 91f8t53afvaolmt017equ9kuuv |
ambrisentanrems.us.com. | TXT | 3600 | TXT Record: H2U5931I1E1UIKTBUDAACJ3APV |
ambrisentanrems.us.com. | TXT | 3600 | TXT Record: 32mi94lc6q6ctrd1ooh31lgl5b |
ambrisentanrems.us.com. | TXT | 3600 | TXT Record: I9MQQGIMD6RRRSR4PI79AQQGS7 |
HTTP/1.1 301 Moved Permanently Content-Length: 0 Location: https://ambrisentanrems.us.com/ Strict-Transport-Security: max-age=31536000; includeSubDomains X-Frame-Options: SAMEORIGIN Date: Wed, 04 May 2022 09:17:33 GMT HTTP/1.1 200 OK Cache-Control: no-cache, no-store, must-revalidate Pragma: no-cache Content-Length: 0 Content-Type: text/html Expires: -1 Strict-Transport-Security: max-age=31536000; includeSubDomains Set-Cookie: UBC-ANONYMOUS-TOKEN=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; path=/; secure; HttpOnly X-Frame-Options: SAMEORIGIN Date: Wed, 04 May 2022 09:17:34 GMT |